To further understand the effects of BSP-1 on MASLD through in vivo and in vitro experiments, we investigated the expression of proteins related to the pyroptosis-related NLRP3/caspase-1/GSDMD pathway. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.